We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
39 hedge funds and large institutions have $9.71M invested in Anavex Life Sciences in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
200% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 5
27% more capital invested
Capital invested by funds: $7.63M → $9.71M (+$2.08M)
26% more funds holding
Funds holding: 31 → 39 (+8)
0% less call options, than puts
Call options by funds: $399K | Put options by funds: $400K
Holders
39
Holders Change
+8
Holders Change %
+25.81%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
15
Reduced
5
Closed
3
Calls
$399K
Puts
$400K
Net Calls
-$1K
Net Calls Change
-$919K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$285K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$253K |
| 4 |
Goldman Sachs
New York
|
+$246K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$223K |
Top Sellers
| 1 |
Jane Street
New York
|
-$570K |
| 2 |
Morgan Stanley
New York
|
-$453K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$345K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$98K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$57.2K |
